Advancing cancer therapies. At the speed of light

Advancing cancer therapies. At the speed of light.

Hemerion® develops a unique and disruptive technology to treat glioblastoma.
A breakthrough therapy for glioblastoma patients

A breakthrough therapy for glioblastoma patients

Promising early clinical results

Promising early clinical results

A disruptive technology to tackle brain cancer and glioblastoma

News

Levée de fonds

Hemerion lève 3,5 millions € pour financer le développement de nouvelles solutions pour le traitement du glioblastome

May 19, 2022

Un an après la première levée de fonds, le nouveau financement de 3,55 M d’euros obtenu par Hemerion permet d'accélérer la mise en place d’essais cliniques internationaux dans le traitement… ...

Read more

First ever patient treated with Hemerion technology

May 12. 2017: the first ever patient treated with Hemerion technology

May 12, 2022

Five years ago, on May, 12th 2017, Pr. Nicolas Reyns delivered, for the first time ever, the therapy currently being developed by Hemerion. It was the first time that this… ...

Read more

Fund raising

Hemerion raises €3.5 million to develop new solutions for the treatment of glioblastoma

April 14, 2022

One year after the first round of funding, Hemerion's new €3.55 million financing will accelerate the implementation of international clinical trials for the treatment of glioblastoma, the most aggressive brain… ...

Read more

mail icon

Stay tuned to our clinical advances

Subscribe to our newsletter